ANNOUNCEMENT

MedCity CONVERGE July 9-10 in Philly gathers payers, providers, medtech, pharma, digital health, policymakers & more.

Topic: rheumatology

New medications are helping people with rheumatoid arthritis

New medications are helping people with rheumatoid arthritis

March 2, 2013 9:10 am by | 0 Comments

People will see Vicki Iverson-Wolter and say she looks good. They don't see the debilitating effects of arthritis."Just because people look good on the outside, sometimes we don't always understand ... Read more
A rheumatoid arthritis test and app to track disease levels could improve drug choices

A rheumatoid arthritis test and app to track disease levels could improve drug choices

January 25, 2013 3:46 pm by | 0 Comments

One of the many challenges of a rheumatoid arthritis diagnosis is the condition’s variability from patient to patient and over time. This unpredictability also impacts the effectiveness of drugs used ... Read more
Joint fluid testing firm using biomarkers to detect infection, disease raises $5M

Joint fluid testing firm using biomarkers to detect infection, disease raises $5M

June 20, 2012 5:15 pm by | 0 Comments

A firm that has developed joint fluid assays for orthopedic and rheumatology practices has raised just about all of its $5 million target to bring its tests to market. The ... Read more
Experimental lupus therapy from Argos in partnering talks after strong phase 1

Experimental lupus therapy from Argos in partnering talks after strong phase 1

June 8, 2012 1:24 pm by | 1 Comments

 The experimental lupus treatment being developed by Argos Therapeutics is showing promise in early stage clinical trials, but the questions remain whether it’s enough progress to attract interest from a ... Read more
Cardinal Health launches infusion therapy tool for rheumatology practices

Cardinal Health launches infusion therapy tool for rheumatology practices

January 6, 2012 2:04 pm by | 0 Comments

Pharmaceuticals distributor Cardinal Health (NYSE:CAH) has launched a web-based tool to help rheumatology practices better manage infusion therapy patients.Cardinal’s new InfusaTrack software is designed to make it easier for community ... Read more
GSK and HGSI test injectable version of lupus drug Benlysta

GSK and HGSI test injectable version of lupus drug Benlysta

December 15, 2011 11:32 am by | 0 Comments

GlaxoSmithKline (NYSE:GSK) and drug partner Human Genome Sciences (NASDAQ:HGSI) have started clinical trials on a different version of lupus drug Benlysta that would be easier to administer to patients.Benlysta is ... Read more
Cleveland Clinic researcher gets $1.1M grant for lupus study

Cleveland Clinic researcher gets $1.1M grant for lupus study

August 25, 2011 11:25 am by | 0 Comments

A Cleveland Clinic researcher has received a $1.1 million grant from the U.S. Department of Defense to study why lupus is so much more prevalent in females than males.Trine Jorgensen, ... Read more
Philadelphia osteoporosis drugmaker Zelos raises $2.8 million

Philadelphia osteoporosis drugmaker Zelos raises $2.8 million

August 23, 2011 4:49 pm by | 0 Comments

A Philadelphia-area pharmaceutical company developing innovative treatments for bone disorders has raised fresh capital, likely working toward the commercialization of an osteoporosis treatment.Zelos Therapeutics has raised $2.8 million, according to ... Read more
Benlysta benchmarks: Progress of the GSK-HGSI lupus treatment so far

Benlysta benchmarks: Progress of the GSK-HGSI lupus treatment so far

August 12, 2011 1:00 pm by | 0 Comments

It’s been five months since new lupus drug Benlysta became the first new U.S. Food and Drug Administration-approved lupus treatment in 56 years. Since receiving FDA approval, GlaxoSmithKline (NYSE:GSK) and ... Read more
What Argos Therapeutics plans to do with $86M from an IPO

What Argos Therapeutics plans to do with $86M from an IPO

July 29, 2011 6:55 pm by | 0 Comments

Immunotherapy company Argos Therapeutics plans to start enrolling patients in a phase 3 kidney cancer trial for its lead candidate in the fourth quarter.But first, Argos needs money. The company ... Read more
Lupus drug Benlysta gets European approval for GSK, HGSI

Lupus drug Benlysta gets European approval for GSK, HGSI

July 14, 2011 11:49 am by | 0 Comments

Lupus drug Benlysta is two-for-two this week.GlaxoSmithKline (NYSE:GSK) and drug partner Human Genome Sciences (NASDAQ:HGSI) said Thursday that the European Commission has granted marketing authorization for Benlysta, an announcement that ... Read more
GSK’s lupus drug Benlysta gets Health Canada approval

GSK’s lupus drug Benlysta gets Health Canada approval

July 12, 2011 1:03 pm by | 0 Comments

Lupus drug Benlysta, developed by GlaxoSmithKline (NYSE:GSK) and drug partner Human Genome Sciences (NASDAQ:HGSI), can now count Canada among the markets where it will offer the first new lupus treatment ... Read more
LabCorp offer to buy Orchid extended to July 15; FTC still reviewing deal

LabCorp offer to buy Orchid extended to July 15; FTC still reviewing deal

June 16, 2011 12:21 pm by | 0 Comments

LabCorp‘s (NYSE:LH) deadline to buy DNA testing services firm Orchid Cellmark (NASDAQ:ORCH) has been extended to July 15, the third extension for the deal in the last month.The Burlington, North ... Read more
Drug partnering as strategy: How BioCryst plans to move its pipeline

Drug partnering as strategy: How BioCryst plans to move its pipeline

May 26, 2011 1:53 pm by | 0 Comments

BioCryst Pharmaceuticals CEO Jon Stonehouse got a jump on Memorial Day weekend travel. Today, Stonehouse is in London where he will tell European doctors and healthcare professionals how BioCryst’s experimental ... Read more
NIH grants, GSK’s Benlysta lupus breakthrough (Weekend Rounds)

NIH grants, GSK’s Benlysta lupus breakthrough (Weekend Rounds)

March 12, 2011 8:00 am by | 0 Comments

Among the life science current events from last week: NIH grant rankings, lessons from GSK's Benlysta lupus drug breakthrough, Medtronic's battle with GPOs, the self-creation of a urethra, and debates ... Read more